| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/05/2007 | WO2005097127A3 Method of treating men with metabolic and anthropometric disorders |
| 07/05/2007 | WO2005081742A3 Testosterone oral dosage formulations and associated methods |
| 07/05/2007 | WO2004083381A3 Fibroblast growth factor receptor-1 polynucleotides, polypeptides, and mutants |
| 07/05/2007 | WO2004043226A3 Methods for predicting whether subjects with mild cognitive impairment (mci) will develop alzheimer's disease |
| 07/05/2007 | US20070157331 Protection of female reproductive system from natural and artifical insults |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070155990 Crystalline form of beta2 adrenergic receptor agonist |
| 07/05/2007 | US20070155989 Trifluoroacetate blocking of alanine amino group, friedel crafts reaction with methoxybenzene, reduction of carbonyl group, chlorosulphonation and deprotection; claimed tamsulosin intermediates; simplification |
| 07/05/2007 | US20070155970 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
| 07/05/2007 | US20070155967 Process for producing piperidine-2,6 diones heterocyclically substituted in the 3-position |
| 07/05/2007 | US20070155966 Heterocyclic imines such as 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide, used for prophylaxis of hepatitis C virus (HCV) |
| 07/05/2007 | US20070155965 Substituted bicyclic imidazo-3-ylamine compounds |
| 07/05/2007 | US20070155950 Alkylated poly(allylamine) polymers and methods of use |
| 07/05/2007 | US20070155842 Method of treating skin requiring Intense Pulse Light (IPL) procedure |
| 07/05/2007 | US20070155841 Preventive agent for carcinogenesis of liver cancer containing quinone-based compound as active ingredient |
| 07/05/2007 | US20070155839 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene) methyl]benzoic acid; selective estrogen receptor modulation; SERMS |
| 07/05/2007 | US20070155838 New Method for Treating Urinary Disorders |
| 07/05/2007 | US20070155837 administering daily dose of creatine to the individual wherein the daily dose of creatine range from about 0.35 mg to 3.5 mg per kilogram body weight; and also administering a dose of amantadine to treat nocturia an urogenital disorder |
| 07/05/2007 | US20070155836 17a-Hydroxy-7,17a-dimethyl-D-homoestr-4-en-3-one; 7,17a-dimethyl-D-homoestr4-en-3-one; male hormone replacement therapy;androgen insufficiency; minimal risk of bone decalcification (trabecular bone mineral density (BMD) loss) and liver toxicity; androgen insufficency; oral administration |
| 07/05/2007 | US20070155835 Use of ortho-phenylphenol and/or derivatives thereof for inhibiting the asexual reproduction of fungi |
| 07/05/2007 | US20070155834 Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors |
| 07/05/2007 | US20070155833 Oxaliplatin formulations |
| 07/05/2007 | US20070155832 Use of sulfonamide compounds for the treatment of diabetes and/or obesity |
| 07/05/2007 | US20070155831 Reacting 3-(1-hydroxyalkylidene)-3H-benzofuran-2-one compounds or their 3-alkanoyl-3H-benzofuran-2-one ketonic tautomeric forms in the presence of a concentrated acid catalyst; intermediate for the antiarrhythmic dronedarone |
| 07/05/2007 | US20070155830 Human immunodeficiency virus (HIV); inhibit the reproduction of HIV and delay the destruction of human immune system; bromination, nitration and alkylation |
| 07/05/2007 | US20070155829 Agent for controlling bcl-2 expression comprising ginsenoside f1 as an active component |
| 07/05/2007 | US20070155828 Side effect reduction; develop coumarin analogs for use as drugs which would directly mimic treatments for which Sodium Warfarin is used; improved controllability within their therapeutic range |
| 07/05/2007 | US20070155827 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression |
| 07/05/2007 | US20070155826 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
| 07/05/2007 | US20070155825 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| 07/05/2007 | US20070155824 Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis |
| 07/05/2007 | US20070155823 Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
| 07/05/2007 | US20070155822 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| 07/05/2007 | US20070155821 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| 07/05/2007 | US20070155820 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
| 07/05/2007 | US20070155819 Calcilytic compounds |
| 07/05/2007 | US20070155818 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist |
| 07/05/2007 | US20070155817 Indolylmaleimide derivatives |
| 07/05/2007 | US20070155816 CDK(Cyclin-dependent kinase) inhibitor; cancer, apoptosis; 5-NH-trimethyl-indirubin-3-oxime |
| 07/05/2007 | US20070155815 Salinosporamides and methods for use thereof |
| 07/05/2007 | US20070155814 Immunomodulatory compositions |
| 07/05/2007 | US20070155813 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 07/05/2007 | US20070155812 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents |
| 07/05/2007 | US20070155811 5-chloro-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-(4,5-dicyano-1H-imidazol-2-yl)-3-methyl-1H-pyrazol; useful for combating these parasites in warm-blooded vertebrates |
| 07/05/2007 | US20070155810 Enzyme inhibitors as bactericides for infections and enzyme inhibitors |
| 07/05/2007 | US20070155809 e.g. 4-isopropyl-6-(5-mercapto-4-(4-methoxy-3-(propylamino)phenyl)-4H-1,2,4-triazol-3-yl)benzene-1,3-diol; Heat Shock Protein 90 (HSP90) modulator; antiproliferative, anticarcinogenic, antiinflammatory agent; angiogenesis inhibition, infections |
| 07/05/2007 | US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid |
| 07/05/2007 | US20070155807 Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents |
| 07/05/2007 | US20070155806 Novel luciferin derivatives |
| 07/05/2007 | US20070155805 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease |
| 07/05/2007 | US20070155804 Mitotic kinesin inhibitor |
| 07/05/2007 | US20070155803 Protease inhibitors |
| 07/05/2007 | US20070155801 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 07/05/2007 | US20070155800 Application methods to rapidly alter disease and injury states using molecular transport of B6 |
| 07/05/2007 | US20070155799 Carbonates of fenicol antibiotics |
| 07/05/2007 | US20070155798 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes torezolid phosphate |
| 07/05/2007 | US20070155796 Crystals of benzimidazole compounds |
| 07/05/2007 | US20070155795 Muscarinic agonists |
| 07/05/2007 | US20070155794 3-(1H-indol-2-yl)-5-phenylpyridin-2(1H)-one; autoimmune, inflammatory, proliferative, or hyperproliferative disease or an immunologically-mediated disease |
| 07/05/2007 | US20070155793 4-(5-aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 07/05/2007 | US20070155792 Enzyme inhibitors as bactericides for infections and as enzyme inhibitors |
| 07/05/2007 | US20070155791 Methods for treating cutaneous lupus using aminoisoindoline compounds |
| 07/05/2007 | US20070155790 Meta-benzamidine derivatives as serine protease inhibitors |
| 07/05/2007 | US20070155789 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155787 Amine salt of carbostyril derivative |
| 07/05/2007 | US20070155786 Methods for treating oral aphthous stomatitis and oral mucositis |
| 07/05/2007 | US20070155785 Hydroxamic acid compounds and methods of use thereof |
| 07/05/2007 | US20070155784 Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
| 07/05/2007 | US20070155783 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 07/05/2007 | US20070155782 Nk-1 receptor antagonists anesthesia recovery |
| 07/05/2007 | US20070155781 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase |
| 07/05/2007 | US20070155780 Stabilized composition containing 4-amino-5-chloro-n-[(1r, 3r, 5s)-8-methyl-8-azabicyclo[3.2.1]oct-3-y1]-2-[1-methylbut-2-ynyloxy]benzamide |
| 07/05/2007 | US20070155779 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 07/05/2007 | US20070155778 4-Trifluoromethoxyphenoxybenzol-4-Sulfonic Acids, Method For The Production And Use Thereof In Medicaments |
| 07/05/2007 | US20070155777 Antiinflammation agents |
| 07/05/2007 | US20070155776 Thienopyridine and furopyridine kinase inhibitors |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155774 Oral formulations of desoxypeganine and thereof uses |
| 07/05/2007 | US20070155773 Use of Tiotropium Salts in the Treatment of Moderate Persistent Asthma |
| 07/05/2007 | US20070155772 Use of genetic polymorphisms that associate with efficacy of treatment of inflammatory disease |
| 07/05/2007 | US20070155771 Methods and means for treating protein conformational disorders |
| 07/05/2007 | US20070155770 Treatment of anoragasmia or delayed orgasm |
| 07/05/2007 | US20070155769 Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders |
| 07/05/2007 | US20070155768 Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| 07/05/2007 | US20070155767 Sulfone substituted imidazo ring ethers |
| 07/05/2007 | US20070155766 GTPase inhibitors and methods of use and crystal structure of RAC-1 GTPase |
| 07/05/2007 | US20070155765 Method of preparation of the hemi-calcium salt of (e)-7-[4-(4fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonvl)aminolpyrimidin-5-yl](3r,5s)-3,5-, dihvdroxy-6-heptenoic acid |
| 07/05/2007 | US20070155764 Novel substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases |
| 07/05/2007 | US20070155763 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto |
| 07/05/2007 | US20070155762 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase |
| 07/05/2007 | US20070155761 Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 07/05/2007 | US20070155760 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors |
| 07/05/2007 | US20070155759 Using 1-acylpiperidine substance P antagonists; gastrointestinal disorders, analgesics, antiinflammatory agents, central nervous system disorders, rheumatic diseases |
| 07/05/2007 | US20070155758 tyrosine kinase inhibitor; cancer, retinopathy, psoriasis |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155755 An N-acylated conjugate between 2-isopropyl-5-methyl-cyclohexanecarboxylic acid and the amino group of a sympathomimetic drug, anadrenergic stimulants; coolants; vasoconstriction; sensory discomfort; pruritis, skin disorders, analgesics, antitussive and -inflammatory agents; long-lasting effect |
| 07/05/2007 | US20070155754 Histamine h3 receptor antagonists, preparation and therapeutic uses |
| 07/05/2007 | US20070155753 5-(Arylsulfonyl)-Pyrazolopiperidines |
| 07/05/2007 | US20070155752 2-Amino-o4-substituted pteridines and their use as inactivators of o6-alkylguanine-dna alkyltransferase |